Alvotech (ALVO) Change in Account Payables (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Account Payables came in at -$34.3 million in Q1 2026, down 1001.76% YoY from $3.8 million in Q1 2025, and down 146.88% on a QoQ basis from $73.2 million in Q4 2025.
Alvotech (ALVO) Change in Account Payables (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Change in Account Payables data on file, last reported at -$34.3 million in Q1 2026.
- Quarterly Change in Account Payables fell 1001.76% year-over-year to -$34.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 180.53% YoY) and the FY2025 annual result came in at $45.3 million, up 430.87% from the prior year.
- Change in Account Payables fell to -$34.3 million in Q1 2026, from $73.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $73.2 million in Q4 2025 to a low of -$45.7 million in Q3 2025.
- A 5-year average of $1.3 million and a median of $6.6 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables soared 634.86% — and 2026, when it tumbled 1001.76%.
- Tracing ALVO's Change in Account Payables over 5 years: stood at $6.6 million in 2022, then soared by 393.11% to $32.3 million in 2023, then slumped by 142.35% to -$13.7 million in 2024, then soared by 634.86% to $73.2 million in 2025, then plunged by 146.88% to -$34.3 million in 2026.
- The last three Change in Account Payables figures came in at -$34.3 million (Q1 2026), $73.2 million (Q4 2025), and -$45.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -34.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.34 Mn |
| Mar 31, 2026 | -34.34 Mn |
| Dec 31, 2025 | 73.25 Mn |
| Dec 31, 2025 | 73.25 Mn |
| Sep 30, 2025 | -45.69 Mn |
| Sep 30, 2025 | -45.69 Mn |
| Jun 30, 2025 | 13.95 Mn |
| Jun 30, 2025 | 13.95 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Dec 31, 2024 | -13.70 Mn |
| Dec 31, 2024 | -13.70 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | -28.93 Mn |
| Mar 31, 2024 | -28.93 Mn |
| Dec 31, 2023 | 32.34 Mn |
| Dec 31, 2023 | 32.34 Mn |